Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
about
Dual function of CD81 in influenza virus uncoating and buddingIFITM proteins restrict viral membrane hemifusion.Entry inhibitors: New advances in HCV treatmentChronic hepatitis C virus infection and lipoprotein metabolismAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesThe hepatitis C virus glycan shield and evasion of the humoral immune responseDecoding protein networks during virus entry by quantitative proteomicsStructural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization EscapeFusion of Enveloped Viruses in Endosomes.Hunting Viral Receptors Using Haploid CellsRegulated Entry of Hepatitis C Virus into Hepatocytes.Rubella virus: first calcium-requiring viral fusion protein.Hepatitis C virus life cycle and lipid metabolismInteraction of human tumor viruses with host cell surface receptors and cell entryFlunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.Hepatitis C virus host cell entry.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.Hepatitis C virus-host interactions, replication, and viral assemblyDisulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.Hepatitis C virus: virology and life cycleExtracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery.The ins and outs of hepatitis C virus entry and assembly.CD81 and hepatitis C virus (HCV) infection.How hepatitis C virus invades hepatocytes: the mystery of viral entryUnderstanding the hepatitis C virus life cycle paves the way for highly effective therapies.Hepatitis C virus entry: beyond receptors.Virus-neutralizing antibodies to hepatitis C virus.Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion.The Hemagglutinin-Esterase Fusion Glycoprotein Is a Primary Determinant of the Exceptional Thermal and Acid Stability of Influenza D Virus.An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus EntryHepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81.A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.Hepatitis C virus: Morphogenesis, infection and therapy.
P2860
Q21558775-D4E3E2BE-451B-4023-B0A4-704CC6A1B145Q21558779-54A42C14-2565-4DB3-8464-E42073481D98Q26770817-D50B0673-9891-4EB3-BE88-9D319FFC838EQ26784234-9DDD47AF-E4C4-4ABC-AA21-246F7EBA1A89Q26992256-A6CD60B2-46F0-426C-8C59-358EE6FB4C66Q27023390-D77149C4-3578-465A-8B74-5B1313615F74Q27469058-3C69D558-5B24-44CB-AFC5-6E2EBF9B2E51Q27678252-85CB8A60-E3A6-4F40-AE85-7B9D74FB0E75Q28073406-7D8339DD-B369-4567-9D74-91C605F10DFAQ28080327-AA30626B-6183-471D-AD0B-564E1607C758Q33753913-26DBA51C-8A21-4490-B181-F667C49BC6E9Q34633762-61485B06-0B07-4DA7-BC0D-4BCB64EA97FFQ34792436-FDC1E521-BC1E-499A-881E-E4EBF1A152E6Q35676027-59171C08-6320-4C5D-BE87-46970910BF69Q35739094-6F06DE17-3EA1-4C3B-9332-4791DB35E7A1Q35851742-1838FA9F-F5DF-4D3E-8F92-017202BAE9FCQ35914270-980A78AF-EED2-497C-9B83-A24E90AE950AQ36086218-B1531C6C-8355-416D-818E-7D04E41F3091Q36427976-22933806-9429-44E5-B282-F591BA8E2080Q36559948-26C10C87-9F68-4FBA-9999-A7E5C3EC03B9Q36698602-05743B65-1D65-4CF1-8995-5F402F6E784EQ36756358-8292302D-2AEF-4B2A-8E12-CA187E30072AQ36902474-EF4794E1-5C1B-4564-BDAA-62EC99A46B85Q37498626-621A16D6-D276-44D7-BBA2-307AEB2296AEQ37611819-D5D1A1EA-6C22-4CAC-8B3D-9AB0FB526C92Q37682499-C62CBB07-0A9D-465E-8A35-42C16C48C735Q37699395-ED631295-9DBA-4C48-A792-BEE615130320Q37990884-26DCC160-34E1-4B5A-8803-DA9A07DD28E4Q38104471-EE24CA50-C1C9-4788-A266-527D38E3E2BEQ38195180-3997414A-F49A-4E89-A6C6-1B4CF1CFCBE4Q38624712-954D85C6-C055-41A0-B222-9E2241DFBD80Q38723923-4056D27D-D6DB-47A1-8943-D03F59F7DDE2Q38771712-17E21E4F-C4DD-4F07-92C8-CB3578F2E8F9Q38849121-9CFE8863-B147-4A5B-A454-98A42E464CEAQ39303797-96171063-4E77-4F8F-AC5A-68E81846167CQ39318833-3D5E9487-8B30-4211-A068-E140B25FB525Q43046695-A658ABB3-F103-4D0B-838B-2CD4C2AE2EAAQ46453274-85DDD377-1055-4EF8-9CCC-6E7ED83A8347Q51149647-04CB91A3-19DA-4847-A5C9-25482F1FF32AQ52661702-E49C62E8-A438-43D1-A79A-337D373F40FB
P2860
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
@ast
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
@en
type
label
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
@ast
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
@en
prefLabel
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
@ast
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
@en
P2093
P2860
P356
P1476
Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion
@en
P2093
Arash Grakoui
Gregory B Melikyan
Guaniri Mateu
Nishi R Sharma
P2860
P304
30361-30376
P356
10.1074/JBC.M111.263350
P407
P577
2011-07-07T00:00:00Z